Henry Schein (NASDAQ:HSIC) Receives Outperform Rating from Barrington Research

Barrington Research reaffirmed their outperform rating on shares of Henry Schein (NASDAQ:HSIC) in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a $82.00 price objective on the stock. Barrington Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.20 EPS, Q1 2025 earnings at $1.12 EPS, Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.27 EPS, Q4 2025 earnings at $1.46 EPS, FY2025 earnings at $5.12 EPS and FY2026 earnings at $5.80 EPS.

Other equities research analysts have also issued research reports about the stock. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. StockNews.com lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, Evercore ISI raised their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $77.50.

Henry Schein Price Performance

Shares of HSIC traded down $1.09 during trading hours on Wednesday, hitting $68.92. The stock had a trading volume of 141,276 shares, compared to its average volume of 1,350,931. The company’s fifty day moving average is $70.59 and its two-hundred day moving average is $69.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein has a 52 week low of $62.12 and a 52 week high of $82.63. The stock has a market capitalization of $8.73 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 2.08 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The company’s revenue was up .4% on a year-over-year basis. On average, analysts anticipate that Henry Schein will post 4.74 EPS for the current year.

Insider Transactions at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.14% of the stock is currently owned by insiders.

Institutional Trading of Henry Schein

A number of institutional investors have recently made changes to their positions in the business. Empirical Finance LLC lifted its position in shares of Henry Schein by 3.5% in the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after purchasing an additional 160 shares in the last quarter. Cromwell Holdings LLC increased its holdings in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Covestor Ltd increased its holdings in Henry Schein by 12.8% during the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after buying an additional 171 shares during the last quarter. Simplify Asset Management Inc. increased its holdings in Henry Schein by 5.0% during the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after buying an additional 175 shares during the last quarter. Finally, Sequoia Financial Advisors LLC increased its holdings in Henry Schein by 3.2% during the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after buying an additional 176 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.